Sickle cell disease in Germany - Disease manifestations, therapeutic options and possibilities for improvement of care;Sichelzellkrankheit in Deutschland - Krankheitsmanifestationen, therapieoptionen und möglichkeiten der optimierung der betreuung

Klinische Padiatrie

Volumn 218, Issue 3, 2006, Pages 165-169

  Dickerhoff, R ^a  

^a Asklepios Kinderklinik ^*  (Germany)

Author keywords

Acute chest syndrome; Sickle cell disease; Splenic sequestration

Indexed keywords

ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DEATH; GENOTYPE; GERMANY; HEALTH CARE DELIVERY; HEALTH CENTER; HUMAN; INTEGRATION; MAJOR CLINICAL STUDY; SICKLE CELL ANEMIA; ADOLESCENT; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HEALTH SURVEY; INFANT; LIFE EXPECTANCY; MALE; MIGRATION; MORTALITY; MULTIMODALITY CANCER THERAPY; NEWBORN; PRESCHOOL CHILD; SURVIVAL RATE;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; EMIGRATION AND IMMIGRATION; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; INFANT; INFANT, NEWBORN; LIFE EXPECTANCY; MALE; POPULATION SURVEILLANCE; SURVIVAL RATE;

EID: 33744491308     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-933406     Document Type: Article

References (25)

1. Adams RJ, McKie VC, Hsu L, Files B, Vichinsky E, Pegelow C, Abboud M, Gallagher D, Kutlar A, Nichols FT, Bonds DR, Brambilla D. Prevention of a first stroke by transfusion in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography, N Engl J Med 1998; 339: 5-11
2. Adams RJ, Pavlakis S, Roach ES. Sickle cell disease and stroke: primary prevention and transcranial doppler. Ann Neurol 2003; 54: 559-563
3. Amrolia PJ, Almeida A, Halsey C, Roberts IA, Davies SC. Therapeutic challenges in childhood sickle cell disease. Br J Hematol 2003; 120: 725-743
4. Bardakdjian-Michau J, Guilloud-Bataille M, Maier-Redelsperger M, Elion J, Girot R, Feingold J, Galacteros F, de Montalembert M. Decreased morbidity in homozygous sickle cell disease detected at birth. Hemoglobin 2002; 26: 211-217
5. Bellet PS, Kalinyak KA, Shukla R, Gelfand MJ, Rucknagel DL. Incentive spirometry to prevent acute pulmonary complications in sickle cell disease. N Engl J Med 1995; 333: 699-703
6. Booz MMY, Hariharan V, Aradi AJ, Malki AA. The value of ultrasound and aspiration in differentiating vaso-occlusive crisis and osteomyelitis in sickle cell disease patients. Clinical Radiology 1999; 54: 636-639
7. Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, McMahon RP, Bonds DR. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N Engl J Med 1995; 332: 1317-1322
8. Claster S, Vichinsky EP. Managing sickle cell disease. Br Med J 2003; 327: 1151-1155
9. Davis H, Schoendorf KC, Gergen PJ, Moore RM. National trends in the mortality of children with sickle cell disease, 1968 through 1992. Am J Public Health 1997; 87: 1317-1322
10. Dickerhoff R, Rücker A von, Konne E. Sichelzellerkrankungen in Deutschland. Verlaufsbeobachtungen über 10 Jahre. Dt Ärztebl 1998; 95: 1675-1679
11. Dickerhoff R. Milzsequestrationen bei Patienten mit Sichelzellerkrankungen. Klin Pädiatr 2002; 214: 70-73
12. Dickerhoff R, Kulozik AE. Sichelzellerkrankung. In: Gaedicke G, Gadner H, Ritter J, Niemeyer C. Pädiatrische Onkologie und Hämatologie. Springer, Heidelberg 2005
13. Emond AM, Collis R, Darville D, Higgs DR, Maude GH, Serjeant GR. Acute splenic sequestration in homozygous sickle cell disease: natural history and management. J Pediatr 1985; 107: 201-206
14. Gray A, Anionwu EN, Davies SC, Brozovic M. Patterns of mortality in sickle cell disease in the United Kingdom. J Clin Pathol 1991; 44: 459-463
15. Halsey C, Roberts IA. The role of hydroxyurea in sickle cell disease. Br J Hematol 2003; 120: 177-186
16. Ohene-Frempong K. Sickle cell disease in the United States of America and Africa. Hematology (Am Soc Hematol Educ Program) 1999; 64-72
17. Orringer EP, Fowler VG, Owens CM, Johnson AE, Mauro MA, Dalldorf FG, Croom RD. Case report: Splenic infarction and acute splenic sequestration in adults with hemoglobin SC disease. Am J Med Sci 1991; 302: 374-379
18. Powars D, Diagnosis at birth improves survival of children with sickle cell anemia. Pediatrics 1989; 83: 830-833
19. Platt OS, Brambilla DJ, Rosse WF, Milner PF, Castro O, Steinberg MH, Klug PP. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-1644
20. Quinn CT, Rogers ZR, Buchanan GR. Survival of children with sickle cell disease. Blood 2004; 103: 4023-4027
21. Rees DC, Olujohungbe AD, Parker NE, Stephens AD, Telfer P, Wright J. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Hematology 2003; 120: 744-752
22. Steinberg MH, Barton F, Castro O, Pegelow CH, Ballas SK, Kutlar A, Orringer E, Bellevue R, Olivieri N, Eckman J. Varma M, Ramirez G, Adler B, Smith W, Carlos T, Ataga K, DeCastro L, Bigelow C, Saunthararajah Y, Telfer M, Vichinsky E, Claster S, Shurin S, Bridges K, Waclawiw M, Bonds D, Terrin M. Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia. JAMA 2003; 289: 1645-1651
23. Stuart MJ, Setty BNJ. Sickle cell acute chest syndrome: Pathogenesis and rationale for treatment. Blood 1999; 94: 1555-1560
24. Stuart MJ, Nagel R. Sickle cell disease. Lancet 2004; 364: 1343-1360
25. www.haemoglobin.uni-bonn.de